Filter
7914
Filtered Results: 7914
Text search:
use
of
medicines
Featured
Recommendations
730
New Publications
1908
Language
Document type
No document type
4193
Studies & Reports
1478
Guidelines
1067
Manuals
427
Strategic & Response Plan
264
Fact sheets
182
Training Material
142
Situation Updates
63
Resource Platforms
30
Brochures
29
Infographics
18
Online Courses
15
Videos
4
App
2
Countries / Regions
India
371
Global
325
Kenya
221
South Africa
189
Ethiopia
159
Uganda
147
Western and Central Europe
142
Nepal
138
Sierra Leone
138
Nigeria
133
Africa
133
Liberia
120
Tanzania
119
Malawi
116
Latin America and the Carribbean
115
Bangladesh
107
Zambia
99
Myanmar / Burma
95
Ukraine
91
Ghana
88
Rwanda
83
Syria
81
Philippines
65
Congo, Democratic Republic of
62
Eastern Europe
59
South–East Asia Region
53
Namibia
53
Zimbabwe
52
Russia
51
Brazil
49
Mozambique
43
Asia
41
West and Central Africa
41
East and Southern Africa
41
Lesotho
40
Guinea
36
Cambodia
36
Middle East and North Africa
36
Senegal
35
Indonesia
35
Burkina Faso
34
Germany
34
South Sudan
33
Haiti
30
Cameroon
29
Venezuela
29
Eastern Europe and Central Asia
27
Botswana
27
Yemen
26
Eswatini/ Swaziland
20
Benin
19
Colombia
18
USA
18
Sudan
18
Afghanistan
17
Pakistan
17
Thailand
16
Peru
16
Vietnam
16
Lebanon
15
Madagascar
15
China
13
Jordan
13
Moldova
13
Mali
13
Western Pacific Region
12
Paraguay
11
North America
11
Sri Lanka
11
Somalia
11
Tajikistan
10
Georgia
10
Central African Republic
10
Albania
9
Ecuador
9
North Macedonia
8
Mexico
8
Laos
8
United Kingdom
8
Kyrgyzstan
7
Spain
7
Southern Africa
7
Côte d’Ivoire / Ivory Coast
7
Bolivia
7
Angola
7
Iraq
7
Turkey
6
Chile
6
Argentina
6
Egypt
6
Palestine
6
Kazakhstan
5
Iran
5
Niger
5
Jamaica
5
Belarus
5
Papua New Guinea
5
Poland
5
Libya
5
El Salvador
4
Canada
4
Estonia
4
Burundi
4
Morocco
4
Guinea-Bissau
4
Hungary
4
Saudi Arabia
4
Portugal
4
Chad
4
Bhutan
4
Timor Leste/ East Timor
3
Serbia
3
Gambia
3
Fiji
3
Malaysia
3
Qatar
3
Armenia
3
Turkmenistan
3
Japan
3
France
3
Mauritius
3
Tunisia
3
Romania
3
Guatemala
3
Congo-Brazzaville
2
Uzbekistan
2
Mongolia
2
Bulgaria
2
Mauritania
2
Lithuania
2
Gabon
2
South Korea
2
Israel
2
Bosnia and Herzegovina
2
Nicaragua
2
Greece
2
Switzerland
1
Australia
1
Togo
1
Singapore
1
Italy
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
French Guyana
1
Latvia
1
Djibouti
1
Slovakia
1
Honduras
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2825
Clinical Guidelines
659
Public Health
466
Women & Child Health
366
Key Resources
322
Capacity Building
165
Pharmacy & Technologies
91
Annual Report MEDBOX
3
Toolboxes
COVID-19
699
Mental Health
691
HIV
632
TB
434
AMR
350
NTDs
280
Caregiver
245
Disability
235
Pharmacy
233
Planetary Health
223
NCDs
221
Ebola & Marburg
199
Rapid Response
184
Conflict
170
Refugee
135
Global Health Education
117
Health Financing Toolbox
86
Natural Hazards
74
Zika
49
Specific Hazards
40
Social Ethics
38
Cholera
25
Polio
22
Malaria
12
This study was aimed to ascertain the clinical profile and management of patients with ischemic heart disease (IHD) and/or peripheral artery disease (PAD). In this observational and cross-sectional study developed in 80 hospitals throughout Spain, consecutive adults with stable IHD and/or PAD were i...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
The Asthma Control Questionnaire (ACQ)1 was developed and validated to measure the primary clinical goal of asthma management as identified by international guidelines. They indicate that to achieve good control, treatment should minimise day and night time symptoms, activity limitation, airway narr...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income and middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population’s median 10-year predicted CVD risk, including its variation within countries by socio-demographic char...
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp...
The aim of these Guidelines is to provide a framework for the conservation and sustainable use of plants in medicine. To do this, the Guidelines describe the various tasks that should be carried out to ensure that where medicinal plants are taken from the wild, they are taken on a basis that is sust...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
Using an inhaler is the most common and effective way of taking asthma medicines. If you’re NOT using your inhaler correctly, you might not be getting the full dose of medicine your doctor or asthma nurse prescribed because the medicine can’t reach your
lungs. Instead it might be hitting the ba...
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Website last accessed on 14.04.2023
One of the ongoing challenges with neglected tropical diseases (NTDs) is that the discovery of medicines to treat them has been very slow. Current global programmes for NTDs largely depend on donated medicines, primarily to treat the world’s poorest people ...
The Priority medicines for mothers and children 2011 list was updated following the 18th Expert Committee Meeting
on Selection and Use of Medicines, the release of new treatment guidelines and feedback from partners following
the 2011 version. In alignment with the UN Global strategy f...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
Chapter 16: Managing medicine selection - Key topics: the concept of essential medicines; selection of essential medicines and development of essential medicines lists, formularies, and treatment guidelines. - The rationale for selecting a limited number of essential medicines is that it may lead ...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in ...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
